Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub‐analysis of a randomized, placebo‐controlled, double‐blind, crossover trial
Year: 2017
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12884
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G6433152044
OpenAlex ID: W2591646518
